Tri-Site Academic Center Experience with Immunotherapy for Metastatic Skin Cancer in Solid Organ Transplant Patients.

Hannah S Berman,Catherine A Degesys,Leila Tolaymat

Southern medical journal（2023）

引用 0|浏览0

暂无评分

摘要

ICIs can be used in organ transplant patients, but the risk of transplant rejection must be carefully discussed because it may be associated with an increased risk of death. A higher risk of rejection exists with anti-programmed cell death 1 and anti-programmed cell death ligand 1 inhibitors.

查看译文

关键词

immune checkpoint inhibitor,melanoma,organ transplant,skin cancer,squamous cell carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要